READ MOREAkston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston

READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

READ MOREAkston Biosciences Receives U.S. Patent for Once-A-Week Human Insulin

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

READ MOREAkston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

READ MOREAkston and LakePharma Announce Strategic Partnership to Manufacture AKS-452

READ MOREAkston Biosciences Receives $2.5M Milestone Payment

READ MOREAkston Biosciences Awarded NIDDK Phase IIb Grant